Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for non-motor symptoms and pain in Parkinson's disease
RBR-3tvjjkxPhase 3Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol in Parkinson's disease (PD) and chronic pain (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Nov 2022; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
Parkinson's disease (PD)chronic pain
Beyond the preview
Go deeper on RBR-3tvjjkx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3tvjjkx.